S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway

Nuwellis (NUWE) Competitors

$0.59
0.00 (0.00%)
(As of 03/1/2024 ET)

NUWE vs. TIVC, HSDT, BSGM, SPRC, ATXI, SIEN, GBNH, NAOV, EVOK, and ALLR

Should you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include Tivic Health Systems (TIVC), Helius Medical Technologies (HSDT), BioSig Technologies (BSGM), SciSparc (SPRC), Avenue Therapeutics (ATXI), Sientra (SIEN), Greenbrook TMS (GBNH), NanoVibronix (NAOV), Evoke Pharma (EVOK), and Allarity Therapeutics (ALLR). These companies are all part of the "medical" sector.

Nuwellis vs.

Tivic Health Systems (NASDAQ:TIVC) and Nuwellis (NASDAQ:NUWE) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, community ranking, earnings, dividends, media sentiment, risk, valuation, institutional ownership and analyst recommendations.

In the previous week, Nuwellis had 2 more articles in the media than Tivic Health Systems. MarketBeat recorded 4 mentions for Nuwellis and 2 mentions for Tivic Health Systems. Nuwellis' average media sentiment score of 0.43 beat Tivic Health Systems' score of 0.30 indicating that Tivic Health Systems is being referred to more favorably in the media.

Company Overall Sentiment
Tivic Health Systems Neutral
Nuwellis Neutral

Nuwellis has a net margin of -191.82% compared to Nuwellis' net margin of -672.78%. Tivic Health Systems' return on equity of -141.02% beat Nuwellis' return on equity.

Company Net Margins Return on Equity Return on Assets
Tivic Health Systems-672.78% -185.91% -134.45%
Nuwellis -191.82%-141.02%-90.34%

9.6% of Tivic Health Systems shares are held by institutional investors. Comparatively, 2.1% of Nuwellis shares are held by institutional investors. 2.7% of Tivic Health Systems shares are held by insiders. Comparatively, 0.9% of Nuwellis shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tivic Health Systems
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Nuwellis
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Tivic Health Systems has higher earnings, but lower revenue than Nuwellis. Nuwellis is trading at a lower price-to-earnings ratio than Tivic Health Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tivic Health Systems$1.84M1.13-$10.10M-$42.48-0.03
Nuwellis$8.54M0.23-$14.52M-$16.22-0.04

Nuwellis received 19 more outperform votes than Tivic Health Systems when rated by MarketBeat users.

CompanyUnderperformOutperform
Tivic Health SystemsN/AN/A
NuwellisOutperform Votes
19
50.00%
Underperform Votes
19
50.00%

Tivic Health Systems has a beta of 2.94, meaning that its stock price is 194% more volatile than the S&P 500. Comparatively, Nuwellis has a beta of 0.18, meaning that its stock price is 82% less volatile than the S&P 500.

Summary

Tivic Health Systems and Nuwellis tied by winning 7 of the 14 factors compared between the two stocks.


Get Nuwellis News Delivered to You Automatically

Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NUWE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NUWE vs. The Competition

MetricNuwellisElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$1.92M$3.38B$5.22B$7.62B
Dividend YieldN/A1.71%2.82%3.87%
P/E Ratio-0.0415.31256.0118.81
Price / Sales0.2374.153,092.03110.62
Price / CashN/A49.36100.0155.35
Price / Book0.034.154.534.54
Net Income-$14.52M$95.15M$114.95M$211.55M
7 Day Performance-3.40%2.99%5.72%3.36%
1 Month Performance22.96%8.25%12.81%6.70%
1 Year Performance-92.35%42.43%12.93%7.44%

Nuwellis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TIVC
Tivic Health Systems
0 of 5 stars
$1.22
+0.8%
N/A-93.8%$1.79M$1.84M-0.0316Short Interest ↑
Gap Down
HSDT
Helius Medical Technologies
1.1733 of 5 stars
$5.51
-2.1%
$85.00
+1,442.6%
-68.5%$3.91M$790,000.00-0.2626Short Interest ↑
Gap Up
BSGM
BioSig Technologies
0 of 5 stars
$0.51
+6.3%
N/A-93.1%$4.58M$141,000.00-0.1147Short Interest ↑
Gap Up
High Trading Volume
SPRC
SciSparc
0 of 5 stars
$3.91
+4.5%
N/A-79.3%$2.03M$1.35M0.003Short Interest ↓
News Coverage
Gap Up
ATXI
Avenue Therapeutics
4.0688 of 5 stars
$0.15
+6.9%
$32.00
+20,612.0%
-86.2%$2.05MN/A-0.262Short Interest ↓
Gap Down
SIEN
Sientra
0.7033 of 5 stars
$0.17
-18.7%
$7.50
+4,210.3%
N/A$2.08M$90.55M-0.03304Analyst Report
Gap Down
GBNH
Greenbrook TMS
3.6917 of 5 stars
$0.05
-59.3%
$3.00
+6,150.0%
-95.5%$1.96M$69.10M-0.02492Gap Down
NAOV
NanoVibronix
0 of 5 stars
$1.02
flat
N/A-76.1%$2.09M$750,000.000.009Upcoming Earnings
Short Interest ↑
EVOK
Evoke Pharma
0 of 5 stars
$0.63
flat
N/A-77.6%$2.11M$2.51M-0.284Analyst Report
Short Interest ↓
Gap Up
ALLR
Allarity Therapeutics
0 of 5 stars
$0.40
+5.3%
N/A-99.8%$1.91MN/A0.0014Upcoming Earnings

Related Companies and Tools

This page (NASDAQ:NUWE) was last updated on 3/3/2024 by MarketBeat.com Staff